Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Polish Journal of Pharmacology and Pharmacy|November 1, 1991
Locomotor hyperactivity induced by MK-801 in ratsJ Maj, Z Rogóz, G SkuzaPolish Journal of Pharmacology|December 14, 1999
Pharmacological profile of milnacipran, a new antidepressant, given acutelyZ Rogóz, G Skuza, J MajPolish Journal of Pharmacology|July 1, 1996
Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligandsJ Maj, Z Rogóz, G SkuzaJournal of Neural Transmission (Vienna, Austria : 1996)|January 29, 2000
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?J Maj, Z Rogóz, G SkuzaPolish Journal of Pharmacology and Pharmacy|May 1, 1992
The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in ratsJ Maj, Z Rogóz, G SkuzaEuropean Journal of Pharmacology|July 9, 1982
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activityJ Maj, Z Rogóz, G SkuzaPolish Journal of Pharmacology|July 1, 1993
Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in miceJ Maj, Z Rogóz, G SkuzaJournal of Neural Transmission. General Section|January 1, 1991
Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in ratsJ Maj, Z Rogóz, G SkuzaJournal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activityJ Maj, G Skuza, Z RogózPolish Journal of Pharmacology|May 1, 1993
Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effectsJ Maj, Z Rogóz, G SkuzaPageof 19